Standard Anthem prior authorization for Wegovy CarelonRx prior authorization for Wegovy generally requires: BMI 30 or higher, or BMI 27 with documented comorbidities (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea) Documentation of participation in a structured weight-management program for typically 6 months Demonstration of medical necessity by the prescribing clinician Sometimes, prior trial of formulary alternatives such as phentermine or contrave Attestation that contraindications are absent (personal or family history of medullary thyroid carcinoma or MEN 2 syndrome) Initial approval is typically 6 months, with continuation requiring documentation of clinically meaningful weight loss (usually 5% or more) at reauthorization
Lttl and its pharmacies were not independently audited
Statistical analysis Descriptive statistics Descriptive statistics are presented as numbers and proportions (%), means and standard deviations (SD), or medians and interquartile ranges (IQR)
It is expressed on the cell surface of various cell types including endothelial and immune cells and in tissues like the liver and kidney
Monofunctional heme-catalases
Presented for research literature review only Conlon TM et al